Physician profile
Mark Ray Dalton
NPI 1457324816
$1,922,834.35
in general payments reported to CMS, 2019-2025
9 companies · $75K in 2025
The $75K reported for 2025 was more than what 93% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267K · 2020: $158K · 2021: $491K · 2022: $401K · 2023: $347K · 2024: $183K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $378K · Royalty Or License: $171K · Travel and Lodging: $48K · Food and Beverage: $8,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $377,666.25 |
| Royalty Or License | $171,057.45 |
| Travel and Lodging | $47,806.83 |
| Food and Beverage | $8,693.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,871,414.34 | 2019-2025 | Portfolio, Apex 3d, Monkey Rings |
| Osteocentric Technologies, INC. | $49,964.90 | 2019-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Wright Medical Technology, INC. | $557.20 | 2019 | |
| Stryker Corporation | $416.88 | 2020-2023 | Infinity, 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $144.78 | 2019 | |
| Medinc of Texas | $120.00 | 2022 | |
| Medline Industries LP | $117.42 | 2024 | |
| Medartis INC. | $54.30 | 2021 | |
| Boston Scientific Corporation | $44.53 | 2022-2023 | Truselect |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$12,486,316.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.